University of Southern California
Robert Gellibolian, Ph.D, is the Founder and CEO of CellectGen, Inc., a company focused on developing a decentralized saliva-based screening test for periodontal disease. In addition to this role, Robert serves as a Clinical Associate Professor at the University of Southern California, teaching graduate courses in pathology. Previously, Robert contributed as a Scientific Member on the Institutional Review Board at St. Vincent Medical Center and as an Entrepreneur In Residence at Children's Hospital Los Angeles. Robert has founded multiple companies, including PhD Nootrition and N-Abl Therapeutics, and has extensive experience as a reviewer for the National Institutes of Health. Robert holds a Ph.D. in Biochemistry, Biophysics, and Molecular Biology from Texas A&M University and completed postdoctoral studies at the Salk Institute for Biological Studies.
This person is not in any teams
This person is not in any offices